tldrdaily.news logo
Tag

Hv1 Variant

All articles tagged with #hv1 variant

health2 years ago

Rapid Spread of HV.1 Subvariant Raises Concerns in US

A new highly contagious COVID-19 variant called HV.1, a sublineage of omicron XBB.1.9.2 and a descendent of EG.5, is spreading across US states and accounted for 30% of new infections in December. Similar to other variants, HV.1 exhibits symptoms such as fever, cough, shortness of breath, fatigue, muscle aches, headache, loss of taste or smell, sore throat, congestion, runny nose, nausea, and diarrhea. Experts suggest that congestion, sore throat, and dry cough are the most prominent symptoms, and while the illness is milder and doesn't require hospitalization, testing is necessary to distinguish it from other respiratory illnesses.

via Hindustan Times|
#cdc#covid-19#health
health2 years ago

"Rapid Spread of HV.1 Variant Sparks Concerns in US and UK"

The HV.1 variant of COVID-19, also known as omicron, has become the most prevalent strain in the United States, accounting for nearly one-third of cases nationwide. This variant is highly transmissible, and experts advise keeping an eye on its spread. The Centers for Disease Control and Prevention recommends getting an updated COVID-19 vaccine, staying home if sick, getting tested if needed, seeking treatment if at high risk, and wearing a high-quality mask that fits well.

via KPRC Click2Houston|
#cdc#covid-19#health
health2 years ago

Thanksgiving Travelers Brace for HV.1 Variant Surge, Warn Doctors

Health officials are warning Thanksgiving travelers of an increase in COVID, flu, and RSV cases in the Bay Area, with expectations of surges during the holiday season. The new variant HV.1 is a concern, particularly for unvaccinated individuals. Masks are recommended at airports, where passenger traffic is expected to reach pre-pandemic levels. Free COVID test kits can be delivered to homes to prepare for the winter surge.

via KGO-TV|
#covid-cases#flu#health
health2 years ago

Rapid Spread of HV.1 and JN.1 Covid Variants Raises Concerns

The highly contagious HV.1 variant of Covid-19 is rapidly spreading across the United States, accounting for over a quarter of all cases since the end of October. HV.1 is dominating other strains, including the globally dominant EG.5 variant. Health officials are examining the variant to prepare for a potential winter surge. HV.1 is closely related to the Omicron subvariants and is associated with symptoms such as sore throat, congestion, cough, headache, fatigue, and muscle aches. While scientists are not overly concerned about HV.1, there are more highly mutated strains that could pose greater risks.

via Hindustan Times|
#contagious#covid-19#health
health-and-wellness2 years ago

Unveiling the Latest COVID Variants: HV.1 and JN.1

The HV.1 variant, a descendant of the omicron variant, has become the dominant strain in the U.S., accounting for about 25% of COVID-19 infections. Despite its increased transmissibility, experts believe that vaccines and treatments will remain effective against severe infections caused by HV.1. However, vaccine uptake has been low, and health experts emphasize the importance of getting vaccinated, wearing masks in crowded spaces, and practicing good hand hygiene to protect against COVID-19. Testing and early treatment are also crucial in preventing complications.

via AARP|
#covid-19#health-and-wellness#hv1-variant
health2 years ago

HV.1 Variant Takes Over as U.S. Booster Program Falls Behind

The HV.1 variant of the coronavirus, a mutation of the EG.5 variant, has become dominant in the United States, accounting for 25% of cases. Experts say it is more transmissible but not more likely to cause severe disease. While concerns are raised over America's slow booster vaccine program, with less than 3% of Americans having received a booster shot, Covid cases and hospitalizations are currently declining. However, experts warn that colder weather and upcoming holiday gatherings could lead to an increase in cases. The HV.1 variant has been detected in over 41 countries, including the UK, Canada, and Israel, and has several mutations on its spike protein. The US is rolling out an updated booster vaccine based on the XBB.1.5 variant, which experts believe will still be effective against HV.1.

via Daily Mail|
#booster-vaccine#covid-19#health
health2 years ago

The Rise of HV.1: A Dominant COVID Variant Emerges

The HV.1 variant of COVID-19 has become the dominant strain circulating in the United States, accounting for over a quarter of reported cases. Experts suggest that HV.1 may be more transmissible and have the potential to bypass prior immunity. However, there is no evidence yet that it causes more severe infections. The new COVID boosters from Pfizer and Moderna, designed to target XBB variants, are expected to offer some protection against HV.1. However, the uptake of the updated boosters has been low, with only 3.5% of the U.S. population receiving them. The CDC recommends the updated shots for everyone six months and older.

via The Messenger|
#booster-shots#covid-19#health
health2 years ago

The Rise of HV.1: The Dominant Winter COVID Variant

Health authorities in the United States are monitoring a new COVID-19 variant, HV.1, which is rapidly spreading and may replace the current dominant variant, EG.5. HV.1 is responsible for nearly 20% of all COVID-19 cases in the country. While highly transmissible, experts are not concerned about this variant, as it is unlikely to be more serious than other circulating variants. Symptoms of HV.1 are similar to other COVID-19 symptoms. The updated COVID-19 vaccine is expected to provide protection against HV.1, as it is based on a variant closely related to HV.1.

via WION|
#cdc#covid-19#health
health2 years ago

Understanding HV.1: Symptoms and Prevention of the Latest COVID Variant

HV.1 is a rapidly spreading COVID-19 variant in the U.S., accounting for nearly 20% of cases. It is a descendant of the Omicron strain and has changes to its spike protein. While its contagiousness is not yet fully understood, experts believe it is transmissible. However, there is currently no cause for alarm as it does not appear to cause more severe disease than other variants. Symptoms are similar to previous strains, with more cold-like symptoms reported. The updated COVID-19 vaccine is expected to provide protection against HV.1, and there is no evidence suggesting an increased risk of long COVID. Precautions such as vaccination, hand hygiene, and avoiding sick individuals are recommended.

via Prevention Magazine|
#contagious#covid-19#health